Can a scanner instantly tell if a lung biopsy is good enough?

NCT ID NCT05393154

First seen Aug 18, 2026 ยท Last updated Aug 18, 2026

Summary

This study tests a new scanner that uses light-based imaging to quickly check whether small lung tissue samples taken during a bronchoscopy are adequate for diagnosis. The goal is to see if the scanner can accurately tell apart samples that are usable from those that aren't, compared to standard pathology. If it works, it could help doctors avoid repeat procedures and speed up lung cancer diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Aquyre Biopsy Scanner (a device using optical coherence tomography and dynamic cell imaging to view biopsy samples)
What this could lead to
If successful, this scanner could help doctors quickly know if a biopsy sample is usable, reducing repeat procedures and speeding up lung cancer diagnosis.
What could go wrong
This is a small pilot study, so the scanner's accuracy is not yet proven. It may not reliably match pathology results, and its performance could vary in real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Boston Medical Center

    Boston, Massachusetts, 02118, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.